(Q39680209)

English

CD38 expression and complement inhibitors affect response and resistance to daratumumab therapy in myeloma

scientific article published on 15 June 2016

In more languages
default values for all languages
No label defined

No description defined

Statements

CD38 expression and complement inhibitors affect response and resistance to daratumumab therapy in myeloma (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit